Indies Pharma Jamaica Limited (JMSE:INDIES)

Indies Pharma Jamaica Revenue

Indies Pharma Jamaica had revenue of 292.38M JMD in the quarter ending July 31, 2026, with 12.44% growth. This brings the company's revenue in the last twelve months to 1.13B, down -1.75% year-over-year. In the fiscal year ending October 31, 2025, Indies Pharma Jamaica had annual revenue of 1.13B, down -2.82%.

• Revenue (ttm): 1.13B
• Revenue Growth: -1.75%
• P/S Ratio: 3.12
• Revenue / Employee: n/a
• Employees: 64
• Market Cap: 3.52B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2025	1.13B	-32.65M	-2.82%
Oct 31, 2024	1.16B	103.52M	9.81%
Oct 31, 2023	1.06B	118.18M	12.61%
Oct 31, 2022	937.28M	90.45M	10.68%
Oct 31, 2021	846.83M	80.88M	10.56%

Data Source: S&P Global Market Intelligence Last updated: Sep 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 28, 2026

Data Sources Report a data error